ILC2s mediate systemic innate protection by priming mucus production at distal mucosal sites

Research output: Contribution to journalArticle

  • External authors:
  • Laura Campbell
  • Jayde Whittingham-Dowd
  • Seona Thompson
  • Burton F. Dickey
  • Anne-Laure Flammar
  • David Artis
  • David A. Schwartz
  • Christopher M. Evans
  • David Thornton
  • Richard Grencis

Abstract

Host immunity to parasitic nematodes requires the generation of a robust type 2 cytokine response, characterized by the production of interleukin 13 (IL-13), which drives expulsion. Here, we show that infection with helminths in the intestine also induces an ILC2-driven IL-13 dependent goblet cell hyperplasia and increased production of mucins (Muc5b and Muc5ac) at distal sites, including the lungs and other mucosal barrier sites. Critically, we show that type 2 priming of lung tissue through increased mucin production inhibits the progression of a subsequent lung migratory helminth infection and limits its transit through the airways. These data show that infection by gastrointestinal dwelling helminths induces a systemic innate mucin response that primes peripheral barrier sites for protection against subsequent secondary helminth infections. These data suggest innate driven priming of mucus barriers may have evolved to protect from subsequent infections with multiple helminth species, which occur naturally in endemic areas.

Bibliographical metadata

Original languageEnglish
JournalJournal of Experimental Medicine
Early online date3 Oct 2019
DOIs
Publication statusPublished - 2019

Related information

Researchers

View all